novo nordisk zepbound - Search News

News

Novo Nordisk, weight and Danish drugmaker

Associated Press News on MSN · 53m

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

The New York Times · 1h

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

CBS News on MSN · 1h

Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual agreement."

3hon MSN

Novo Nordisk Stock Falls on Surprise CEO Departure

U.S.-listed shares of Novo Nordisk declined in premarket trading Friday on the surprise news that CEO Lars Fruergaard ...

The Local - Denmark8m

Danish medicine giant Novo Nordisk's CEO to step down after 'market challenges'

Danish drugmaker Novo Nordisk, known for its blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, said Friday ...

Fierce Pharma1h

Novo to part ways with longtime CEO Lars Fruergaard Jørgensen, citing weight of market pressures

It’s the end of an era at Novo Nordisk as longtime CEO Lars Fruergaard Jørgensen—who recently shepherded the company through ...

Novo Nordisk CEO Jørgensen to Depart With Danish Pharma’s Shares in Freefall

Over his eight years as CEO, Novo’s sales, profits and share price have almost tripled, the company said. However, the shares ...

Fierce Biotech2d

Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs

Novo Nordisk is making yet another bet on obesity, offering Septerna more than $200 million in upfront and near-term payments ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results